Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantation.
University Hospital Tuebingen, Internal Medicine, Dept. of Hematology and Oncology.
G
G
Stuhler
S
S
Knop
M S
MS
Topp
S M
SM
Kröber
U
U
Ernemann
U
U
Herrlinger
H
H
Einsele
L
L
Kanz
H
H
Hebart
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000601:surgery; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007262:Infusions, Intravenous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000601:surgery; D000069283:Rituximab; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab